GTS Securities LLC Sells 41,218 Shares of Danaher Co. (NYSE:DHR)

GTS Securities LLC reduced its holdings in shares of Danaher Co. (NYSE:DHR - Free Report) by 89.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 4,747 shares of the conglomerate's stock after selling 41,218 shares during the period. GTS Securities LLC's holdings in Danaher were worth $1,090,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of DHR. Norges Bank bought a new position in shares of Danaher during the 4th quarter worth about $2,130,740,000. Raymond James Financial Inc. bought a new position in shares of Danaher during the 4th quarter worth about $391,172,000. Two Sigma Advisers LP boosted its position in shares of Danaher by 4,248.8% during the 4th quarter. Two Sigma Advisers LP now owns 1,639,500 shares of the conglomerate's stock worth $376,347,000 after purchasing an additional 1,601,800 shares in the last quarter. Capital World Investors boosted its position in shares of Danaher by 32.7% during the 4th quarter. Capital World Investors now owns 6,361,183 shares of the conglomerate's stock worth $1,460,215,000 after purchasing an additional 1,566,658 shares in the last quarter. Finally, Point72 Asset Management L.P. boosted its position in shares of Danaher by 460.6% during the 4th quarter. Point72 Asset Management L.P. now owns 1,348,544 shares of the conglomerate's stock worth $309,558,000 after purchasing an additional 1,107,998 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Danaher Stock Performance

Shares of DHR stock traded down $1.64 during trading hours on Friday, hitting $188.83. 960,053 shares of the company were exchanged, compared to its average volume of 3,463,136. The firm has a fifty day simple moving average of $193.18 and a 200 day simple moving average of $214.13. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. Danaher Co. has a 52-week low of $171.00 and a 52-week high of $281.70. The stock has a market capitalization of $135.14 billion, a price-to-earnings ratio of 35.79, a P/E/G ratio of 2.66 and a beta of 0.80.

Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.62 by $0.26. Danaher had a net margin of 16.33% and a return on equity of 10.82%. The company had revenue of $5.74 billion during the quarter, compared to analyst estimates of $5.58 billion. Research analysts predict that Danaher Co. will post 7.63 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be paid a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a yield of 0.68%. Danaher's dividend payout ratio is 24.85%.

Insider Activity at Danaher

In other Danaher news, Chairman Steven M. Rales sold 1,250,000 shares of the firm's stock in a transaction on Monday, May 12th. The shares were sold at an average price of $196.74, for a total value of $245,925,000.00. Following the completion of the transaction, the chairman now directly owns 3,105,808 shares of the company's stock, valued at $611,036,665.92. This trade represents a 28.70% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Christopher Paul Riley sold 15,805 shares of the firm's stock in a transaction on Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the completion of the transaction, the executive vice president now directly owns 15,179 shares of the company's stock, valued at approximately $3,005,442. The trade was a 51.01% decrease in their ownership of the stock. The disclosure for this sale can be found here. 11.20% of the stock is owned by company insiders.

Analyst Ratings Changes

DHR has been the topic of a number of research analyst reports. Guggenheim reissued a "buy" rating and set a $250.00 price objective on shares of Danaher in a research report on Wednesday, April 23rd. Wall Street Zen cut shares of Danaher from a "buy" rating to a "hold" rating in a research report on Saturday, May 24th. Stifel Nicolaus raised shares of Danaher from a "hold" rating to a "buy" rating and set a $260.00 price target on the stock in a research report on Friday, March 14th. JPMorgan Chase & Co. dropped their price target on shares of Danaher from $280.00 to $260.00 and set an "overweight" rating on the stock in a research report on Tuesday, April 22nd. Finally, Citigroup reaffirmed a "buy" rating on shares of Danaher in a research report on Monday, April 7th. Five analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $263.24.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.